AUPH insider buying and SEC filings, explained
Aurinia Pharmaceuticals Inc. · CIK 1600620
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$25.1M
Insiders who bought
1
Sold (not marked 10b5-1)
$546K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 10, 2026 | Sale | Stephen P. Robertson (Chief Legal Officer) sold 11,939 shares at about $15.95 ($190K). Holdings down 2% to 588,848 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Aug 21, 2026 | Sale | Stephen P. Robertson (Chief Legal Officer) sold 20,975 shares at about $16.97 ($356K). Holdings down 3% to 600,787 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| May 29–Jun 2, 2026 | Purchase (code P) | Kevin Tang (CEO and Director) bought 814,606 shares indirectly (by entity) between May 29 and Jun 2 at about $15.29 ($12.5M), reported as a purchase (code P). Holdings by entity up 7% to 13,044,106 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jun 2, 2026 |
| Feb 27–Mar 3, 2026 | Purchase (code P) | Kevin Tang (Director) bought 900,000 shares indirectly (by entity) between Feb 27 and Mar 3 at about $14.10 ($12.7M), reported as a purchase (code P). Holdings by entity up 8% to 12,229,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
25 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AUPH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.